Actively Recruiting

Age: 18Years +
MALE
NCT07222436

Circulating Tumor DNA in High Risk Localized Prostate Cancer

Led by University of Pittsburgh · Updated on 2025-10-29

24

Participants Needed

1

Research Sites

105 weeks

Total Duration

On this page

Sponsors

U

University of Pittsburgh

Lead Sponsor

T

The Beckwith Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

This prospective, non-therapeutic translational biomarker study will collect blood in patients with high risk localized prostate cancer prior to prostatectomy.

CONDITIONS

Official Title

Circulating Tumor DNA in High Risk Localized Prostate Cancer

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically confirmed prostate cancer
  • Age 18 years or older
  • ECOG performance status of 0-1
  • Ability to understand and willingness to sign informed consent
  • Willingness to provide serial blood samples
  • Willingness to provide tumor tissue from prostatectomy or biopsy for correlative studies
  • Primary cohort: High-risk localized prostate adenocarcinoma with clinical stage 63 cT3a, Grade Group 4 or 5 (Gleason sum 8-10), and PSA 63 20; non-bulky pelvic lymphadenopathy and indeterminate imaging findings allowed if surgery is appropriate
  • Exploratory cohort: Men with localized prostate adenocarcinoma on active surveillance, biochemically-recurrent prostate adenocarcinoma after local therapy, hormone-sensitive metastatic prostate adenocarcinoma, or metastatic CRPC
Not Eligible

You will not qualify if you...

  • History of another primary cancer within the last 3 years except non-melanomatous skin cancer
  • Receiving androgen deprivation or other systemic therapy for prostate cancer
  • Medical or social conditions that may prevent adherence to the study protocol

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

UPMC Hillman Cancer Center

Pittsburgh, Pennsylvania, United States, 15232

Actively Recruiting

Loading map...

Research Team

B

Brieanna Marino, MS

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Circulating Tumor DNA in High Risk Localized Prostate Cancer | DecenTrialz